Papers
2
Total Citations
17
H-Index
2
About
Dr. Fayek Taha is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for renal tumors, with a particular focus on optimizing outcomes in complex kidney cancer cases. His major contributions are defined by rigorous, multicenter prospective studies that provide granular, real-world data on surgical decision-making. Dr. Taha is the lead author of the landmark NEPRAH study (UroCCR 175), a multicentre prospective cohort that systematically compared robot-assisted partial nephrectomy for hilar versus nonhilar renal masses. This work, which has already garnered 15 citations since its 2024 publication, provides critical perioperative, oncological, and functional outcome data that directly informs surgical planning for challenging tumors. Further demonstrating his commitment to surgical safety, Dr. Taha authored the UroCCR-135 study on open conversion during minimally invasive renal tumor surgery. This research moves beyond simple rate reporting to offer a detailed analysis of the reasons, management, and predictive factors for conversion, equipping surgeons with actionable insights for preparing for the worst-case scenario. Through these high-impact, practice-shaping studies, Dr. Taha is a key voice in the evolution of nephron-sparing surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2